Biotricity Inc. (Biotricity) will officially launch the commercial sales of its FDA cleared, wireless wearable cardiac monitoring device, Biotres, in April 2022.  The product has been available for pre-orders to physicians, medical offices, hospitals and individual use since late-February 2022.

Biotricity Inc. (Biotricity) has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2022.  Biotricity was also highlighted as #1 in this year’s Medical Devices category.  This year’s list honors businesses that are making the biggest impact on their industries and culture as a whole-ultimately thriving in today’s ever-changing world.